A<sub>2A</sub> Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson's Disease. [PDF]
Spinaci A +10 more
europepmc +1 more source
Biofilm proficient Bacillus subtilis prevents neurodegeneration in Caenorhabditis elegans Parkinson's disease models via PMK-1/p38 MAPK and SKN-1/Nrf2 signaling. [PDF]
Francisco M, Grau R.
europepmc +1 more source
Neuroprotective Activity of Oligomeric Stilbenes from Alpha Grape Stems in In Vitro Models of Parkinson's Disease. [PDF]
Pislyagin EA +8 more
europepmc +1 more source
Optimization of Zebrafish Larvae 6-OHDA Exposure for Neurotoxin Induced Dopaminergic Marker Reduction. [PDF]
Romero A +6 more
europepmc +1 more source
Genetically engineered BMSCs promote dopamine secretion and ameliorate motor dysfunction in a Parkinson's disease rat model. [PDF]
Wang C +10 more
europepmc +1 more source
Unconventional secretion of PARK7 requires lysosomal delivery via chaperone-mediated autophagy and specialized SNARE complex. [PDF]
Dash BK +5 more
europepmc +1 more source
Insulin-Like Growth Factor Binding Protein 2 Drives Neurodegeneration in Parkinson's Disease: Insights From In Vivo and In Vitro Studies. [PDF]
An J, Wen L, Yu H, Bu Z, Feng J.
europepmc +1 more source
Stimulation of microneedles alleviates pathology of Parkinson's disease in mice by regulating the CD4+/CD8+ cells from the periphery to the brain. [PDF]
Kim JH +10 more
europepmc +1 more source
Identifying genetic targets in clinical subtypes of Parkinson's disease for optimizing pharmacological treatment strategies. [PDF]
Kong D +9 more
europepmc +1 more source

